reporting season

Antares’ Andrew Hamilton believes the market is missing some key drivers for the global leader in hearing implants.

Australia’s healthcare darling delivered solid results and continued to outflank its competitors on Tuesday.

This building materials company shows why cost advantage is the name of the game.

If someone had said that 2023 would see the strongest start to a trading year in over 20 years, you would have laughed. If someone then said the ASX Accumulation Index...

FNArena's Rudi Filapek-Vandyck believes the issues of 2022 are not fully resolved and reporting season could be 'brutal' for many stocks.

Tipped to hold up better than most, JBH has a few traits others in the space don't, says Hugh Dive of Atlas Funds Management

One of Australia's cheapest and best operators of hotels, alcohol and gaming facilities saw a 17% raise in profits and is set for strength.

Alongside the key things he's watching as first-half FY2023 results roll in, John Guadagnuolo explains how his team decides when to sell

Ratings, consensus price targets, and FNArena insights on each stock covered feature in the following article

Despite the 9% price decline in Aussie housing prices, this real estate advertising company has managed to lift its revenues.